Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7

F L Roudabush1, K L Pierce, S Maudsley

  • 1Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. Luttrell@receptor-biol.duke.edu

Insights

Insulin-like growth factor 1 receptor (IGF-1R) activation triggers epidermal growth factor receptor (EGFR) transactivation, leading to Shc protein phosphorylation and ERK cascade activation. This cross-talk mechanism is crucial for IGF-1

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Receptor tyrosine kinases

Background:

  • Insulin-like growth factor 1 receptor (IGF-1R) signaling pathways regulate cell proliferation and survival.
  • Cross-talk between IGF-1R and epidermal growth factor receptor (EGFR) is implicated in cellular responses.
  • Understanding these interactions is key to deciphering complex cellular signaling networks.

Purpose of the Study:

  • To investigate the role of cross-talk between IGF-1R and EGFR in mediating cellular responses to IGF-1.
  • To elucidate the specific molecular mechanisms underlying IGF-1-induced signaling pathway activation.
  • To determine how IGF-1R activation influences EGFR activity and downstream signaling.

Main Methods:

  • Stimulation of COS-7 cells with IGF-1.
  • Immunoprecipitation assays to detect protein-protein interactions (EGFR-Shc complexes).
  • Western blotting to assess tyrosine phosphorylation of key signaling proteins (IGF-1R, EGFR, IRS-1, Shc, ERK1/2, Akt).
  • Pharmacological inhibition of EGFR kinase (Tyrphostin AG1478), HB-EGF activity ([Glu(52)]Diphtheria toxin), and metalloproteases (1,10-phenanthroline).

Main Results:

  • IGF-1 stimulation induced tyrosine phosphorylation of IGF-1R, EGFR, IRS-1, and Shc.
  • IGF-1R activation led to the assembly of EGFR-Shc complexes.
  • EGFR kinase inhibition significantly reduced IGF-1-stimulated phosphorylation of Shc and ERK1/2, but not IGF-1R, IRS-1, or Akt.
  • IGF-1-mediated ERK activation was dependent on matrix metalloprotease-released heparin-binding EGF (HB-EGF).
  • Distinct mechanisms mediate IGF-1 stimulation of the IRS-1/PI3K/Akt and EGFR/Shc/ERK1/2 pathways.

Conclusions:

  • IGF-1R activation initiates distinct signaling pathways: IRS-1/PI3K/Akt and EGFR/Shc/ERK1/2.
  • "Transactivation" of EGFR by IGF-1R is the primary mechanism for Shc phosphorylation and ERK cascade activation.
  • This cross-talk involves an autocrine loop mediated by HB-EGF release.
  • The findings clarify the differential signaling mechanisms initiated by IGF-1 through its receptor.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...